- ICH GCP
- Registre américain des essais cliniques
- Essai clinique NCT06576310
Facteurs prédictifs des changements occlusaux dans le traitement de l'apnée obstructive du sommeil avec un appareil d'avancement mandibulaire (APNEAMOUVE)
Évaluation des facteurs prédictifs des changements occlusaux dentaires dans le traitement de l'apnée obstructive du sommeil avec un appareil d'avancement mandibulaire
This research addresses obstructive sleep apnea syndrome (OSAS), affecting 6-12% of French adults, often treated with mandibular advancement devices (MADs). MADs may lead to occlusal modifications, causing a 50% treatment abandonment rate. The study employs surface electromyography to assess masticatory muscle activity before and during MAD use, correlating it with occlusal changes after 6 months. The primary goal is to determine dental displacement profiles post-6-month MAD treatment, providing insights for personalized care and minimizing treatment failures.
Aperçu de l'étude
Statut
Les conditions
Intervention / Traitement
Description détaillée
In this exploratory electro-pathophysiological study, our objective is to provide a significant contribution to understanding the underlying mechanisms of occlusal modifications associated with mandibular advancement device (MAD) treatment in patients suffering from obstructive sleep apnea syndrome (OSAS). Drawing from observational data, the researchers aim to identify specific electrophysiological profiles linked to masticatory muscle activity, correlating with occlusal changes after MAD treatment. This innovative approach involves detailed data collection on electrophysiological profiles, initial clinical characteristics pre-treatment, and post-treatment follow-up data. Focusing on patients from the dentistry department at Toulouse University Hospital, the study seeks to establish correlations between muscle activity recorded before and during MAD treatment and occlusal changes, ultimately defining electrophysiological patient profiles. These profiles could potentially guide personalized care, anticipating risks of occlusal modifications and reducing treatment dropouts or failures.
The study utilizes diverse exams-orthopantomogram, optical impressions, surface electromyography, polysomnography, and research questionnaires. Data collected pre- and post-mandibular advancement device treatment for six months will innovatively analyze the links between masticatory muscle activity and occlusal changes, aiming to define specific electrophysiological patient profiles.
In this research, participation in the protocol seamlessly integrates into routine care at the Odontology Department of the Toulouse University Hospital. The visits include the provision of the orthosis at 3 weeks (T1), with EMGs and digital occlusal analysis. The 6-week follow-up visit (T2) adjusts therapeutic propulsion, subjectively resolving symptoms related to OSAS. At the T0 visit, the researchers collect the polysomnographic monitoring before fitting the orthosis (carried out in the patient's reference sleep laboratory) to assess treatment efficiency.(The end-of-research visit (6 months after T0) comprehensively collects data, including questionnaires on stress, anxiety, sleep quality and quantity, oral habits, temporo mandibular dysfunction pain, and quality of life. Moreover, the researchers collect the polysomnographic monitoring after 3 months fitting the orthosis (carried out in the same patient's reference sleep laboratory than before fitting the orthosis).
Type d'étude
Inscription (Estimé)
Contacts et emplacements
Coordonnées de l'étude
- Nom: Constance CUNY, MD
- Numéro de téléphone: +33615282467
- E-mail: cuny.c@chut-toulouse.fr
Lieux d'étude
-
-
-
Toulouse, France
- Recrutement
- University Hospital of Toulouse
-
Contact:
- Stéphanie BRAYER
- Numéro de téléphone: +33 5 61 32 25 09
- E-mail: brayer.s@chu-toulouse.fr
-
-
Critères de participation
Critère d'éligibilité
Âges éligibles pour étudier
Accepte les volontaires sains
Sexes éligibles pour l'étude
Méthode d'échantillonnage
Population étudiée
patients with sleep apnea treated with a mandibular advancement device
La description
Inclusion Criteria:
- Patient with complete dentition (up to second molars)
- Polysomnography or polygraphy
- Diagnosis of OSA
- Patient receiving OAM treatment at the Odontology Department of Toulouse University Hospital
- Patient with contemporary panoramic and lateral cephalometric X-rays (common practice) taken at the time of orthotic treatment
- Individual affiliated with or covered by a social security scheme
- Voluntary, informed, written consent, signed by both participant and investigator (prior to inclusion and any necessary research-related examinations).
Exclusion Criteria:
- Inability to provide informed consent
- Pregnant or breastfeeding patient
- Patient with curators, guardians, or legal protection
Plan d'étude
Comment l'étude est-elle conçue ?
Détails de conception
- Modèles d'observation: COHORT
- Perspectives temporelles: PROSPECTIVE
Cohortes et interventions
Groupe / Cohorte |
Intervention / Traitement |
|---|---|
|
OSA patients with mandibular advancement appliance
Patients with obstructive sleep apnea (OSA) treated with a mandibular advancement device (MAD), monitored for changes in masticatory muscle activity and occlusal modifications over a 6-month period. The study involves routine clinical visits and additional assessments including electromyography (EMG) with and without the appliance, optical impressions, digital occlusion recordings, patient diaries, and questionnaires on quality of life, temporo mandibular dysfunction pain, oral habits, stress and anxiety, and sleep evaluation. |
In this research, participation in the protocol seamlessly integrates into routine care at the Odontology Department of the University Hospital of Toulouse. The visits include the provision of the orthosis at 3 weeks (T1), with EMGs and digital occlusal analysis. The 6-week follow-up visit (T2) adjusts therapeutic propulsion, subjectively resolving symptoms related to OSAS. At the T0 visit, the researchers collect the polysomnographic monitoring before fitting the orthosis (carried out in the patient's reference sleep laboratory) to assess treatment efficiency. The end-of-research visit (6 months after T1) comprehensively collects data, including questionnaires on stress, anxiety, sleep quality and quantity, oral habits, temporo mandibular dysfunction pain, and quality of life. Moreover, the researchers collect the polysomnographic monitoring after 3 months fitting the orthosis (carried out in the same patient's reference sleep laboratory than before fitting the orthosis). |
Que mesure l'étude ?
Principaux critères de jugement
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
OCCLUSAL MODIFICATIONS AFTER 6 MONTHS OF OAM TREATMENT
Délai: 6 month
|
assessment of occlusal modifications after 6 months of mandibular advancement device (OAM) treatment. Dental occlusion will be measured using digital occlusal analysis with OCCLUSENS® (Bausch; Köln, Germany), considering the extent of contacts (centroid) and their intensity (%), and through morphometric analysis based on optical impressions obtained pre and post-treatment using the TRIOS optical camera (3Shape, Dentsply®) |
6 month
|
|
PRIMARY EXPOSURE VARIABLE: MASTICATORY MUSCLE ACTIVITY
Délai: 6 month
|
The primary exposure of interest is the activity of masticatory muscles measured by EMG, in the form of motor-evoked potentials (MEPs in µV/s). This measurement will be conducted at the T1 visit when the orthosis is provided to the patient (3 weeks after inclusion) and 6 months after the inclusion visit. At each measurement time, surface EMG will be conducted bilaterally (4 locations in total), both with and without OAM. The association between muscle activity at inclusion and occlusal modifications will be studied for the primary objective, while the association between muscle activity after 6 months of treatment and occlusal modifications will be explored as a secondary objective. |
6 month
|
Autres mesures de résultats
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
OSA phenotype at T0 visit
Délai: baseline
|
The phenotype is classified as:
|
baseline
|
|
initial sleep assesment
Délai: baseline
|
Sleep will be assessed with polysomnography Oxygen desaturation index A normal oxygen saturation level should be about 96 to 97%. When blood oxygen levels drop below 90% Oxygen Desaturation Index is considered slightly abnormal. When blood oxygen levels dip even lower to 80 or 89%, they are considered moderately abnormal. Any blood oxygen levels below 80% are considered severe. |
baseline
|
|
Therapeutic mandibular advancement assessed at the T2 visit
Délai: 6 weeks
|
As a percentage of voluntary mandibular protrusion and in mm of advancement |
6 weeks
|
|
Titration modality assessed at the T2 visit
Délai: 6 weeks
|
Conventional and with a medical titration aid device |
6 weeks
|
|
difference in Patient's clinical characteristics at 6 months
Délai: 6 months
|
Difference in : - Body Mass Index (BMI), |
6 months
|
|
Clinical characteristics
Délai: 6 months
|
- Duration of MAD wear, |
6 months
|
|
Clinical characteristics
Délai: 6 months
|
- Frequency of MAD wear. |
6 months
|
|
Patient's quality of life
Délai: baseline
|
Measured by the Short Form Survey (SF-36) |
baseline
|
|
Patient's quality of life
Délai: 6 months
|
Measured by the SF-36 questionnaire. Scoring the 36-Item Health Survey is a two-step process. First, all items are scored so that a high score defines a more favorable health state. In addition, each item is scored on a 0 to 100 range so that the lowest and highest possible scores are 0 and 100, respectively. Scores represent the percentage of total possible score achieved. In step 2, items in the same scale are averaged together to create the 8 scale scores. Items that are left blank (missing data) are not taken into account when calculating the scale scores. Hence, scale scores represent the average for all items in the scale that the respondent answered. |
6 months
|
Collaborateurs et enquêteurs
Parrainer
Les enquêteurs
- Chercheur principal: Constance CUNY, MD, University Hospital, Toulouse
Dates d'enregistrement des études
Dates principales de l'étude
Début de l'étude (Réel)
Achèvement primaire (Estimé)
Achèvement de l'étude (Estimé)
Dates d'inscription aux études
Première soumission
Première soumission répondant aux critères de contrôle qualité
Première publication (Réel)
Mises à jour des dossiers d'étude
Dernière mise à jour publiée (Réel)
Dernière mise à jour soumise répondant aux critères de contrôle qualité
Dernière vérification
Plus d'information
Termes liés à cette étude
Termes MeSH pertinents supplémentaires
- Maladies du système nerveux
- Blessures et Blessures
- Maladies des voies respiratoires
- Troubles respiratoires
- Troubles induits chimiquement
- Troubles du sommeil et de l'éveil
- Apnée
- Troubles du sommeil, intrinsèques
- Dyssomnies
- Empoisonnement
- Syndromes d'apnée du sommeil
- Apnée du sommeil, obstructive
- Morsures et piqûres
- Équipement orthopédique
- Équipement chirurgical
- Équipement et fournitures
- Dispositifs orthophes
- Attelles occlusales
Autres numéros d'identification d'étude
- RC31/24/0024
Informations sur les médicaments et les dispositifs, documents d'étude
Étudie un produit pharmaceutique réglementé par la FDA américaine
Étudie un produit d'appareil réglementé par la FDA américaine
Ces informations ont été extraites directement du site Web clinicaltrials.gov sans aucune modification. Si vous avez des demandes de modification, de suppression ou de mise à jour des détails de votre étude, veuillez contacter register@clinicaltrials.gov. Dès qu'un changement est mis en œuvre sur clinicaltrials.gov, il sera également mis à jour automatiquement sur notre site Web .